Literature DB >> 22951341

Mechanical input restrains PPARγ2 expression and action to preserve mesenchymal stem cell multipotentiality.

Natasha Case1, Jacob Thomas, Zhihui Xie, Buer Sen, Maya Styner, David Rowe, Janet Rubin.   

Abstract

Exercise-generated signals are pro-osteogenic and anti-adipogenic within the marrow. In vitro studies indicate that mechanical signals directly block adipogenic differentiation through activation of β-catenin and by limiting PPARγ2 expression. Whether mechanically generated β-catenin can inhibit adipogenesis during PPARγ transactivation is unknown. We evaluated the ability of mechanical signals to limit adipogenesis in marrow derived mesenchymal stem cells (mdMSC) distal to activation of PPARγ. First, we established that mdMSC attained an adipogenic phenotype within 2-4 days in the presence of rosiglitazone (1-25 μM) and that β-catenin activation via GSK3β inhibition interfered with this process. Similarly, mechanical strain (3600 cycles, 2% strain daily) inhibited adipogenesis at 3 days, preventing rosiglitazone-induced PPARγ upregulation as well as aP2 and adiponectin protein expression. To assess whether a reduction in PPARγ expression was necessary for anti-adipogenic action, PPARγ2 was overexpressed: both mechanical strain and GSK3β inhibition prevented expression of aP2 and adiponectin proteins despite abundant PPARγ2 and its ligand. To understand the fate of single cells experiencing mechanical strain we generated mdMSC from aP2-GFP reporter expressing mice. Rosiglitazone treatment for 3 days induced GFP expression in more than 80% of cells. Sorting by GFP expression revealed that the highest 20% of aP2-GFP expressing cells was responsible for the majority of adipogenic protein expression. This highly expressing GFP fraction had a reduced ability to respond to an osteogenic stimulus: BMP-2 treatment increased osterix by 12-fold in contrast to the 42-fold increase in osterix expression that resulted from BMP-2 treatment of the bottom 75% of GFP expressing cells. This suggested that highly expressing aP2-GFP cells represented more terminally differentiated adipocytes, with reduced multipotentiality. Application of mechanical strain to aP2-GFP mdMSC treated with rosiglitazone caused a two-fold decrease in the size of the upper cell fraction, suggesting that mechanical strain preserved MSC in a multipotent state. Our data show that mechanical strain restricts adipogenesis both by limiting PPARγ2 expression and by preventing PPARγ action, protecting the potential of MSC to enter other lineages.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22951341      PMCID: PMC3535265          DOI: 10.1016/j.bone.2012.08.122

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  37 in total

1.  Mechanical loading regulates NFATc1 and beta-catenin signaling through a GSK3beta control node.

Authors:  Buer Sen; Maya Styner; Zhihui Xie; Natasha Case; Clinton T Rubin; Janet Rubin
Journal:  J Biol Chem       Date:  2009-10-19       Impact factor: 5.157

2.  Donor age and long-term culture affect differentiation and proliferation of human bone marrow mesenchymal stem cells.

Authors:  Merve Zaim; Serap Karaman; Guven Cetin; Sevim Isik
Journal:  Ann Hematol       Date:  2012-03-08       Impact factor: 3.673

Review 3.  Mammalian target of rapamycin (mTOR): conducting the cellular signaling symphony.

Authors:  Kathryn G Foster; Diane C Fingar
Journal:  J Biol Chem       Date:  2010-03-15       Impact factor: 5.157

4.  Development of a rapid culture method to induce adipocyte differentiation of human bone marrow-derived mesenchymal stem cells.

Authors:  Yuichi Ninomiya; Yzumi Sugahara-Yamashita; Yutaka Nakachi; Yoshimi Tokuzawa; Yasushi Okazaki; Masahiko Nishiyama
Journal:  Biochem Biophys Res Commun       Date:  2010-03-03       Impact factor: 3.575

5.  Inhibitory effect of NF-kappaB on 1,25-dihydroxyvitamin D(3) and retinoid X receptor function.

Authors:  P K Farmer; X He; M L Schmitz; J Rubin; M S Nanes
Journal:  Am J Physiol Endocrinol Metab       Date:  2000-07       Impact factor: 4.310

6.  Treadmill training regulates β-catenin signaling through phosphorylation of GSK-3β in lumbar vertebrae of ovariectomized rats.

Authors:  Shumin Bu; Yu Chen; Shouhui Wang; Fan Zhang; Gang Ji
Journal:  Eur J Appl Physiol       Date:  2012-01-18       Impact factor: 3.078

7.  Wnt signaling controls the phosphorylation status of beta-catenin.

Authors:  Mascha van Noort; Jan Meeldijk; Ruurd van der Zee; Olivier Destree; Hans Clevers
Journal:  J Biol Chem       Date:  2002-02-07       Impact factor: 5.157

Review 8.  Exercise and bone mass in adults.

Authors:  Amelia Guadalupe-Grau; Teresa Fuentes; Borja Guerra; Jose A L Calbet
Journal:  Sports Med       Date:  2009       Impact factor: 11.136

9.  Mechanical strain inhibits adipogenesis in mesenchymal stem cells by stimulating a durable beta-catenin signal.

Authors:  Buer Sen; Zhihui Xie; Natasha Case; Meiyun Ma; Clinton Rubin; Janet Rubin
Journal:  Endocrinology       Date:  2008-08-07       Impact factor: 4.736

10.  Beta-catenin levels influence rapid mechanical responses in osteoblasts.

Authors:  Natasha Case; Meiyun Ma; Buer Sen; Zhihui Xie; Ted S Gross; Janet Rubin
Journal:  J Biol Chem       Date:  2008-08-22       Impact factor: 5.157

View more
  24 in total

Review 1.  Obesity-driven disruption of haematopoiesis and the bone marrow niche.

Authors:  Benjamin J Adler; Kenneth Kaushansky; Clinton T Rubin
Journal:  Nat Rev Endocrinol       Date:  2014-10-14       Impact factor: 43.330

2.  Mechanically activated Fyn utilizes mTORC2 to regulate RhoA and adipogenesis in mesenchymal stem cells.

Authors:  William R Thompson; Christophe Guilluy; Zhihui Xie; Buer Sen; Kaitlyn E Brobst; Sherwin S Yen; Gunes Uzer; Maya Styner; Natasha Case; Keith Burridge; Janet Rubin
Journal:  Stem Cells       Date:  2013-11       Impact factor: 6.277

Review 3.  Combating osteoporosis and obesity with exercise: leveraging cell mechanosensitivity.

Authors:  Gabriel M Pagnotti; Maya Styner; Gunes Uzer; Vihitaben S Patel; Laura E Wright; Kirsten K Ness; Theresa A Guise; Janet Rubin; Clinton T Rubin
Journal:  Nat Rev Endocrinol       Date:  2019-06       Impact factor: 43.330

4.  Actin up in the Nucleus: Regulation of Actin Structures Modulates Mesenchymal Stem Cell Differentiation.

Authors:  Janet Rubin; Buer Sen
Journal:  Trans Am Clin Climatol Assoc       Date:  2017

5.  Epigenetic Plasticity Drives Adipogenic and Osteogenic Differentiation of Marrow-derived Mesenchymal Stem Cells.

Authors:  Mark B Meyer; Nancy A Benkusky; Buer Sen; Janet Rubin; J Wesley Pike
Journal:  J Biol Chem       Date:  2016-07-11       Impact factor: 5.157

Review 6.  Chemical and Physical Approaches to Extend the Replicative and Differentiation Potential of Stem Cells.

Authors:  Eun Seong Hwang; Jeong Soo Ok; SeonBeom Song
Journal:  Stem Cell Rev Rep       Date:  2016-06       Impact factor: 5.739

Review 7.  Mechanical regulation of nucleocytoplasmic translocation in mesenchymal stem cells: characterization and methods for investigation.

Authors:  Lucia Boeri; Diego Albani; Manuela Teresa Raimondi; Emanuela Jacchetti
Journal:  Biophys Rev       Date:  2019-10-18

Review 8.  Fat-bone interaction within the bone marrow milieu: Impact on hematopoiesis and systemic energy metabolism.

Authors:  C P Hawkes; S Mostoufi-Moab
Journal:  Bone       Date:  2018-03-15       Impact factor: 4.398

Review 9.  Bone marrow fat and the decline of B lymphopoiesis in rabbits.

Authors:  Domenick E Kennedy; Pamela L Witte; Katherine L Knight
Journal:  Dev Comp Immunol       Date:  2015-11-11       Impact factor: 3.636

10.  Hdac3 Deficiency Increases Marrow Adiposity and Induces Lipid Storage and Glucocorticoid Metabolism in Osteochondroprogenitor Cells.

Authors:  Meghan E McGee-Lawrence; Lomeli R Carpio; Ryan J Schulze; Jessica L Pierce; Mark A McNiven; Joshua N Farr; Sundeep Khosla; Merry Jo Oursler; Jennifer J Westendorf
Journal:  J Bone Miner Res       Date:  2015-08-20       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.